ERBB2 and breast carcinoma: In 2016, Costantino et al. evaluated whether there were significant survival differences between Black (n = 90) and White women (n = 308) diagnosed with HR+/HER2-breast cancer who were diagnosed at an equal-access military healthcare facility [18].